These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 17523679)
1. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines. Jin DY; Tie JK; Stafford DW Biochemistry; 2007 Jun; 46(24):7279-83. PubMed ID: 17523679 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630 [TBL] [Abstract][Full Text] [Related]
3. Structure and function of vitamin K epoxide reductase. Tie JK; Stafford DW Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192 [TBL] [Abstract][Full Text] [Related]
4. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation. Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134 [TBL] [Abstract][Full Text] [Related]
5. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Chu PH; Huang TY; Williams J; Stafford DW Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330 [TBL] [Abstract][Full Text] [Related]
6. Structure of a bacterial homologue of vitamin K epoxide reductase. Li W; Schulman S; Dutton RJ; Boyd D; Beckwith J; Rapoport TA Nature; 2010 Jan; 463(7280):507-12. PubMed ID: 20110994 [TBL] [Abstract][Full Text] [Related]
7. A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states. Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG J Mol Graph Model; 2007 Sep; 26(2):401-8. PubMed ID: 17182266 [TBL] [Abstract][Full Text] [Related]
8. Warfarin and vitamin K compete for binding to Phe55 in human VKOR. Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861 [TBL] [Abstract][Full Text] [Related]
9. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners. Schulman S; Wang B; Li W; Rapoport TA Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15027-32. PubMed ID: 20696932 [TBL] [Abstract][Full Text] [Related]
10. Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions. Sinhadri BCS; Jin DY; Stafford DW; Tie JK Sci Rep; 2017 Dec; 7(1):17632. PubMed ID: 29247216 [TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. Wajih N; Sane DC; Hutson SM; Wallin R J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329 [TBL] [Abstract][Full Text] [Related]
13. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system. Wajih N; Sane DC; Hutson SM; Wallin R J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149 [TBL] [Abstract][Full Text] [Related]
14. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane. Cain D; Hutson SM; Wallin R J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981 [TBL] [Abstract][Full Text] [Related]
15. Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition. Wu S; Chen X; Jin DY; Stafford DW; Pedersen LG; Tie JK Blood; 2018 Aug; 132(6):647-657. PubMed ID: 29743176 [TBL] [Abstract][Full Text] [Related]
16. Functional study of the vitamin K cycle in mammalian cells. Tie JK; Jin DY; Straight DL; Stafford DW Blood; 2011 Mar; 117(10):2967-74. PubMed ID: 21239697 [TBL] [Abstract][Full Text] [Related]
17. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition. Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152 [TBL] [Abstract][Full Text] [Related]
18. Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases. Shen G; Li C; Cao Q; Megta AK; Li S; Gao M; Liu H; Shen Y; Chen Y; Yu H; Li S; Li W FEBS J; 2022 Aug; 289(15):4564-4579. PubMed ID: 35113495 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin. Dutton RJ; Wayman A; Wei JR; Rubin EJ; Beckwith J; Boyd D Proc Natl Acad Sci U S A; 2010 Jan; 107(1):297-301. PubMed ID: 20018758 [TBL] [Abstract][Full Text] [Related]
20. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone. Mukharji I; Silverman RB Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]